Browsing by Subject "G01N 2800/52"

Now showing items 1-9 of 9

    • 2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and methods for their use for the diagnosis of tuberculosis 
      Rao, Jianghong; Xie, Hexin; Cheng Yungfeng; Cirillo, Jeffrey D (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-07-09)
      β-Lactamase substrates and methods for using the substrates to detect β-lactamase and to diagnose tuberculosis.
    • Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria 
      Cirillo, Jeffrey D.; Norman, Michael T. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-01-08)
      The present disclosure provides methods, reagents, systems, and devices that target β lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure ...
    • Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria 
      Cirillo, Jeffrey D.; Norman, Michael T. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-03-30)
      The present disclosure provides methods, reagents, systems, and devices that target .beta. lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present ...
    • Compositions and methods for drug-sensitization or inhibition of a cancer cell 
      Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-09-15)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Compositions and methods for drug-sensitization or inhibition of a cancer cell 
      Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-01-16)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Compositions and methods for drug-sensitization or inhibition of a cancer cell 
      Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-10)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Controlled release vaccines and methods for treating Brucella diseases and disorders 
      Ficht, Thomas A.; Ficht, Allison; Tsolis, Renee; Garry Addams, Leslie; Arenas-Gamboa, Angela M. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-03-09)
      Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
    • Controlled release vaccines and methods of treating Brucella diseases and disorders 
      Ficht, Thomas A.; Ficht, Allison; Tsolis, Renee; Garry Adams, Leslie (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-03-05)
      Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
    • Controlled release vaccines and methods of treating Brucella diseases and disorders 
      Ficht, Thomas A.; Ficht, Allison; Tsolis, Renee; Garry Adams, Leslie (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-03-05)
      Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...